Polymyositis

Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies
Jean-Baptiste Vulsteke, Rita Derua, Sylvain Dubucquoi, Frédéric Coutant, Sebastien Sanges, David Goncalves, Greet Wuyts, Petra De Haes, Daniel Blockmans, Wim A Wuyts, Kristl G Claeys, Ellen De Langhe, Nicole Fabien, Xavier Bossuyt

Annals of the Rheumatic Diseases Apr 2023, 82 (4) 546-555; DOI: 10.1136/ard-2022-222686
Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy
Océane Landon-Cardinal, Hugues Allard-Chamard, Hugo Chapdelaine, Stéphane Doucet, Éric Rich, Josiane Bourré-Tessier

Annals of the Rheumatic Diseases Apr 2023, 82 (4) 579-580; DOI: 10.1136/ard-2022-223541
Myositis as a manifestation of SARS-CoV-2
Maxime Beydon, Kevin Chevalier, Omar Al Tabaa, Sabrina Hamroun, Anne-Sophie Delettre, Marion Thomas, Julia Herrou, Elodie Riviere, Xavier Mariette

Annals of the Rheumatic Diseases Mar 2021, 80 (3) e42; DOI: 10.1136/annrheumdis-2020-217573
In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy
Cécile Bergua, Hélène Chiavelli, Yves Allenbach, Louiza Arouche-Delaperche, Christophe Arnoult, Gwladys Bourdenet, Laetitia Jean, Rachid Zoubairi, Nicolas Guerout, Michael Mahler, Olivier Benveniste, Laurent Drouot, Olivier Boyer

Annals of the Rheumatic Diseases Jan 2019, 78 (1) 131-139; DOI: 10.1136/annrheumdis-2018-213518
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1
Andrew L Mammen, Arun Rajan, Katherine Pak, Tanya Lehky, Livia Casciola-Rosen, Renee N Donahue, Lauren M Lepone, Anastasia Zekeridou, Sean J Pittock, Raffit Hassan, Jeffrey Schlom, James L Gulley

Annals of the Rheumatic Diseases Jan 2019, 78 (1) 150-152; DOI: 10.1136/annrheumdis-2018-213777
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis
Corrado Campochiaro, Giacomo De Luca, Maria De Santis

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e113; DOI: 10.1136/annrheumdis-2019-216070
Response to: ‘Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis’ by Campochiaro et al
Lionel Spielmann, François Séverac, Alain Meyer

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e114; DOI: 10.1136/annrheumdis-2019-216095
Correspondence on ‘Standardisation of myositis-specific antibodies: where are we today?’
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e115; DOI: 10.1136/annrheumdis-2019-216217
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e116; DOI: 10.1136/annrheumdis-2019-216248
Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
Weng Ian Che, Helga Westerlind, Ingrid E Lundberg, Karin Hellgren, Ralf Kuja-Halkola, Marie Holmqvist

Annals of the Rheumatic Diseases Nov 2021, 80 (11) 1461-1466; DOI: 10.1136/annrheumdis-2021-219914

Main menu

Polymyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Polymyositis

Pages